Share Price, page-8825

These comparisons with CSL are doing my head in. CSL was not a tiny business with 25 staff, a virtual office and no labs when it listed. It was a long established, substantial Government enterprise with loads of staff, layers of highly experienced management and every bit of technical kit they needed to keep doing what they had been doing for decades.. NEU is a brilliant nimble small firm with 2 molecules, few staff, no premises, no labs, no sales force, no international presence and no experience at running a major trial or initiating a global product launch.

The execution risks of the "lets be the next CSL" strategy are enormous. These are real challenges which need hundreds of top staff who are real people who can make real mistakes leading to real execution disasters that destroy real value for shareholders and delay the hopes of every real sufferers. You cant just magic this stuff up in a spread sheet.

There are scores of global businesses that have the skills, experience, capital, sales force, contacts, international reach and management to take the great work that NEU has done to the next level and deliver life-changing treatments to thousands of sufferers worldwide. Hopefully in the not too distant future one of them will come knocking at our door with an offer that is life-changing for shareholders and sufferers alike.